$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

Simufilam reduced dementia-related behavior at 9 months on the Neuropsychiatric Inventory (NPI), a clinical tool widely used to measure changes in dementia-related behavior.

The open label study is a true gift which gives us insight on both health and benefit issues and the med looks great on both counts.

$SAVA September 3rd 2021 Remi Barbier said, "I truly believe Cassava Sciences is one clinical program away from greatness.

$SAVA Per press release dec 6 2022, Remi stated administration of drug for OL study completed and he is "THRILLED" with the clinical development, or what he see to this date.

$SAVA , VERA announced positive phase 2b results meeting primary end point.

My prediction: Phase 2 Unbelievable results FDA fast track Phase 3 - go ahead Patients receive sava Market cap 40 B by 2024 Rising to 200 Billion by 2026 Game changer - the only drug in the world to help patients

It reported positive outcomes in pleural mesothelioma patients, including: Improved survival: Study patients lived around 11 months.

PROC data are excellent compared to any combo trials.

But yesterdays paper also has me considering, if there isn't a deal with $mrk or $BMY or some other CPI BP --- That data is Best In Class - best in clinic, best in trial too.

phase II results within weeks!!!

Now phase 3 trial is showing similar results to date where patients are living longer after Galinpepimut-S up to 1.5 year longer is a breakthrough for AML patients.

Positive trial data/results supported with bullish news and sentiment! 4.

The nation’s best means the O'Neal Comprehensive Center in Alabama have access to the latest therapies, cutting-edge clinical trials and the expertise needed to treat their cancer.

Gps is doing what it has done in every single trial and its the reason Patients are living 3 fold longer than patients on best available treatments.

Treatment with GFH009 resulted in 90 to 100 percent cancer inhibition at dose levels equivalent to those already demonstrated to be safe in patients in the ongoing Phase 1 trial with no viable cancer cells at the highest dose levels.

Phase 2/3 is expected to be positive.

$SRNE https://www.youtube.com/watch?v=n6_Ypx6soYQ great product, great clinical results .. expect a new ATH from Scilex this week!

Ji announced favorable phase 3 results in December 2021.

The results have been so good OVYDSO leapt from phase 1 to phase 3.

Also Zero Adverse Effects during Trial 👌.

phase 2/3 ready Each one is a potential all-star.

More then enough to cover SRNE trials for many years.

Sofusa/Enbrel trial was nothing short of incredible 10/10 response is previous NON-RESPONDERS at 50% the previous does.

$SRNE tomorrow great news about CoviMark, Virex, Phase 2 Mpro trial, Semdexa NDA, Abivertinib China/US, MSC trials in US/Brazil, Socazolimab NDA someone bought 1 million shares AH ✅

$SRNE me when we get that positive clinic trials news 😂